Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

D.Western Therapeutics Institute Inc

+ Add to Watchlist


873.0 JPY 10.0 1.13%

As of 02:00:00 ET on 06/02/2015.

Company Profile for D.Western Therapeutics Institute Inc (4576)

D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.

Contact Information

D.Western Therapeutics Institute Inc

1-18-11 Nishiki Naku-ku
Aichi, 460-0003
Phone: 81-52-218-8785
Fax: 81-52-202-1866

Key Executives for D.Western Therapeutics Institute Inc (4576)

Hiroyoshi HidakaChairman/Chief Scientist OfcrYuichi HidakaPresident/CEO
Tetsuya KawakamiDirector

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil